[1] | Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H (2004) The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 76: 314-321. doi:10.1189/jlb.0204117. PubMed: 15123776.
|
[2] | Fickenscher H, H?r S, Küpers H, Knappe A, Wittmann S et al. (2002) The interleukin-10 family of cytokines. Trends Immunol 23: 89-96. doi:10.1016/S1471-4906(01)02149-4. PubMed: 11929132.
|
[3] | Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979. doi:10.1146/annurev.immunol.22.012703.104622. PubMed: 15032600.
|
[4] | Renauld JC (2003) Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 3: 667-676. doi:10.1038/nri1153. PubMed: 12974481.
|
[5] | Braum O, Pirzer H, Fickenscher H (2006) Interleukin-26, an epitheliotropic T-cell cytokine. Antiinflamm Antiallergy Agents Med Chem 5: 275-277.
|
[6] | Braum O, Pirzer H, Fickenscher H (2007) Interleukin-26, a T-cellular activator of epithelial cells. In: A. Zdanov. Class II Cytokines 2007. Trivandrum: Transworld Research Network. pp. 193-200.
|
[7] | Braum O, Pirzer H, Fickenscher H (2012) Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells. Antiinflamm Antiallergy Agents Med Chem 11: 221-229. PubMed: 23106140.
|
[8] | Donnelly RP, Sheikh F, Dickensheets H, Savan R, Young HA et al. (2010) Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev 21: 393-401. doi:10.1016/j.cytogfr.2010.09.001. PubMed: 20947410.
|
[9] | Fickenscher H, Pirzer H (2004) Interleukin-26. Int Immunopharmacol 4: 609-613. doi:10.1016/j.intimp.2004.01.004. PubMed: 15120646.
|
[10] | Knappe A, H?r S, Wittmann S, Fickenscher H (2000) Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus Saimiri. J Virol 74: 3881-3887. doi:10.1128/JVI.74.8.3881-3887.2000. PubMed: 10729163.
|
[11] | Collins PL, Henderson MA, Aune TM (2012) Lineage-specific adjacent IFNG and IL26 genes share a common distal enhancer element. Genes Immun 13: 481-488. doi:10.1038/gene.2012.22. PubMed: 22622197.
|
[12] | Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC (2000) IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 1: 488-494. doi:10.1038/sj.gene.6363716. PubMed: 11197690.
|
[13] | Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R (2004) Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 4: 577-592. doi:10.1016/j.intimp.2004.01.007. PubMed: 15120644.
|
[14] | Wolk K, Kunz S, Asadullah K, Sabat R (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168: 5397-5402. PubMed: 12023331.
|
[15] | H?r S, Pirzer H, Dumoutier L, Bauer F, Wittmann S et al. (2004) The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J Biol Chem 279: 33343-33351. doi:10.1074/jbc.M405000200. PubMed: 15178681.
|
[16] | Corvaisier M, Delneste Y, Jeanvoine H, Preisser L, Blanchard S et al. (2012) IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLOS Biol 10: e1001395. PubMed: 23055831.
|
[17] | Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957. doi:10.1038/nrg2199. PubMed: 17676044.
|
[18] | Esendagli G, Kurne AT, Sayat G, Kilic AK, Guc D et al. (2013) Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon β-1 therapy. J Neuroimmunol 255: 81-84. doi:10.1016/j.jneuroim.2012.10.009. PubMed: 23177721.
|
[19] | Cella M, Fuchs A, Vermi W, Facchetti F, Otero K et al. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725. doi:10.1038/nature07537. PubMed: 18978771.
|
[20] | Hughes T, Becknell B, McClory S, Briercheck E, Freud AG et al. (2009) Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 113: 4008-4010. doi:10.1182/blood-2008-12-192443. PubMed: 19244159.
|
[21] | Chang C, Magracheva E, Kozlov S, Fong S, Tobin G et al. (2003) Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 278: 3308-3313. doi:10.1074/jbc.M208602200. PubMed: 12403790.
|
[22] | Nagem RA, Colau D, Dumoutier L, Renauld JC, Ogata C et al. (2002) Crystal structure of recombinant human interleukin-22. Structure 10: 1051-1062. doi:10.1016/S0969-2126(02)00797-9. PubMed: 12176383.
|
[23] | Trivella DB, Ferreira-Júnior JR, Dumoutier L, Renauld JC, Polikarpov I (2010) Structure and function of interleukin-22 and other members of the interleukin-10 family. Cell Mol Life Sci 67: 2909-2935. doi:10.1007/s00018-010-0380-0. PubMed: 20454917.
|
[24] | Xu T, Logsdon NJ, Walter MR (2005) Structure of insect-cell-derived IL-22. Acta Crystallogr D Biol Crystallogr 61: 942-950. doi:10.1107/S1744309105029222. PubMed: 15983417.
|
[25] | Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J et al. (1995) Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure 3: 591-601. doi:10.1016/S0969-2126(01)00193-9. PubMed: 8590020.
|
[26] | Zdanov A, Schalk-Hihi C, Wlodawer A (1996) Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor. Protein Sci 5: 1955-1962. doi:10.1002/pro.5560051001. PubMed: 8897595.
|
[27] | Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167: 3545-3529. PubMed: 11564763.
|
[28] | Parrish-Novak J, Xu W, Brender T, Yao L, Jones C (2002) Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 277: 47517-47523. doi:10.1074/jbc.M205114200. PubMed: 12351624.
|
[29] | Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV et al. (2004) Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 172: 2006-2010. PubMed: 14764663.
|
[30] | Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR (2006) Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem 281: 35088-35096. doi:10.1074/jbc.M606791200. PubMed: 16982608.
|
[31] | Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T et al. (2001) Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104: 9-19. doi:10.1016/S0092-8674(01)00187-8. PubMed: 11163236.
|
[32] | Sa SM, Valdez PA, Wu J, Jung K, Zhong F et al. (2007) The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178: 2229-2240. PubMed: 17277128.
|
[33] | Wolk K, Witte K, Witte E, Proesch S, Schulze-Tanzil G et al. (2008) Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol 83: 1181-1193. doi:10.1189/jlb.0807525. PubMed: 18281438.
|
[34] | Dambacher J, Beigel F, Zitzmann K, De Toni EN, G?ke B et al. (2009) The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 58: 1207-1217. doi:10.1136/gut.2007.130112. PubMed: 18483078.
|
[35] | Goris A, Heggarty S, Marrosu MG, Graham C, Billiau A et al. (2002) Linkage disequilibrium analysis of chromosome 12q14-15 in multiple sclerosis: delineation of a 118-kb interval around interferon-gamma (IFNG) that is involved in male versus female differential susceptibility. Genes Immun 3: 470-476. doi:10.1038/sj.gene.6363913. PubMed: 12486605.
|
[36] | Goris A, Marrosu MG, Vandenbroeck K (2001) Novel polymorphisms in the IL-10 related AK155 gene (chromosome 12q15). Genes Immun 2: 284-286. doi:10.1038/sj.gene.6363772. PubMed: 11528524.
|
[37] | Vandenbroeck K, Cunningham S, Goris A, Alloza I, Heggarty S et al. (2003) Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis. Arthritis Rheum 48: 2773-2778. doi:10.1002/art.11236. PubMed: 14558082.
|
[38] | Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-220. doi:10.1038/ng.275. PubMed: 19122664.
|
[39] | Manel N, Unutmaz D, Littman DR (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9: 641-649. doi:10.1038/ni.1610. PubMed: 18454151.
|
[40] | Sedwick C (2012) IL-26 kick-starts rheumatoid arthritis. PLOS Biol 10: e1001398. PubMed: 23049483.
|
[41] | Dumoutier L, Lejeune D, H?r S, Fickenscher H, Renauld JC (2003) Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT) 1. Stat 2 and STAT3. Biochem J 370: 391-396.
|
[42] | Kotenko SV (2011) IFN-λs. Curr Opin Immunol 23: 583-590. doi:10.1016/j.coi.2011.07.007. PubMed: 21840693.
|
[43] | Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77. doi:10.1038/nrm1003. PubMed: 12483210.
|
[44] | Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68. doi:10.1038/ni873. PubMed: 12469119.
|
[45] | Witte K, Witte E, Sabat R, Wolk K (2010) IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev 21: 237-251. doi:10.1016/j.cytogfr.2010.04.002. PubMed: 20655797.
|
[46] | Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R et al. (2006) Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44: 896-906. doi:10.1002/hep.21312. PubMed: 17006906.
|
[47] | Boritz E, Gerlach J, Johnson JE, Rose JK (1999) Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J Virol 73: 6937-6945. PubMed: 10400792.
|
[48] | Dalton KP, Rose JK (2001) Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 279: 414-421. doi:10.1006/viro.2000.0736. PubMed: 11162797.
|
[49] | Marschall M, Freitag M, Weiler S, Sorg G, Stamminger T (2000) Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother 44: 1588-1597. doi:10.1128/AAC.44.6.1588-1597.2000. PubMed: 10817714.
|
[50] | Arthur JL, Scarpini CG, Connor V, Lachmann RH, Tolkovsky AM (2001) Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J Virol 75: 3885-3895. doi:10.1128/JVI.75.8.3885-3895.2001. PubMed: 11264377.
|
[51] | Friedrich M, Holzmann R, Sterry W, Wolk K, Truppel A et al. (2003) Ultraviolet B radiation-mediated inhibition of interferon-gamma-induced keratinocyte activation is independent of interleukin-10 and other soluble mediators but associated with enhanced intracellular suppressors of cytokine-signaling expression. J Invest Dermatol 121: 845-852. doi:10.1046/j.1523-1747.2003.12482.x. PubMed: 14632204.
|
[52] | Janssens N, Janicot M, Perera T, Bakker A (2004) Housekeeping genes as internal standards in cancer research. Mol Diagn 8: 107-113. doi:10.2165/00066982-200408020-00005. PubMed: 15527325.
|
[53] | Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H et al. (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6: 821-825. doi:10.1038/77558. PubMed: 10888934.
|
[54] | Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST et al. (2005) IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 289: G960-G968. doi:10.1152/ajpgi.00126.2005. PubMed: 16051921.
|
[55] | Dambacher J, Beigel F, Zitzmann K, Heeg MH, G?ke B et al. (2008) The role of interleukin-22 in hepatitis C virus infection. Cytokine 41: 209-216. doi:10.1016/j.cyto.2007.11.016. PubMed: 18191408.
|
[56] | Lallemand C, Blanchard B, Palmieri M, Lebon P, May E et al. (2007) Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 26: 328-338. doi:10.1038/sj.onc.1209795. PubMed: 16832344.
|
[57] | Hummelshoj L, Ryder LP, Poulsen LK (2006) The role of the interleukin-10 subfamily members in immunoglobulin production by human B cells. Scand J Immunol 64: 40-47. doi:10.1111/j.1365-3083.2006.01773.x. PubMed: 16784489.
|
[58] | Bailey CA, Miller DK, Lenard J (1984) Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells. Virology 133: 111-118. doi:10.1016/0042-6822(84)90429-X. PubMed: 6199890.
|
[59] | Carneiro FA, Bianconi ML, Weissmüller G, Stauffer F, Da Poian AT (2002) Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions. J Virol 76: 3756-3764. doi:10.1128/JVI.76.8.3756-3764.2002. PubMed: 11907215.
|
[60] | Davis HE, Morgan JR, Yarmush ML (2002) Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem 97: 159-172. doi:10.1016/S0301-4622(02)00057-1. PubMed: 12050007.
|
[61] | Davis HE, Rosinski M, Morgan JR, Yarmush ML (2004) Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J 86: 1234-1242. doi:10.1016/S0006-3495(04)74197-1. PubMed: 14747357.
|
[62] | Münch J, Rücker E, St?ndker L, Adermann K, Goffinet C et al. (2007) Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131: 1059-1071. doi:10.1016/j.cell.2007.10.014. PubMed: 18083097.
|
[63] | Roan NR, Münch J, Arhel N, Mothes W, Neidleman J et al. (2009) The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J Virol 83: 73-80. doi:10.1128/JVI.01366-08. PubMed: 18945786.
|
[64] | Crack LR, Jones L, Malavige GN, Patel V, Ogg GS (2012) Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus. Clin Exp Dermatol 37: 534-543. doi:10.1111/j.1365-2230.2012.04305.x. PubMed: 22639919.
|
[65] | Hazrati E, Galen B, Lu W, Wang W, Ouyang Y et al. (2006) Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 177: 8658-8666. PubMed: 17142766.
|
[66] | Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A (2009) Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83: 440-453. doi:10.1128/JVI.01864-08. PubMed: 18971266.
|